REVVITY ESPANA SL secures contract for Laboratory reagents Supply of reagents for the detection of spinal muscular atrophy SMA and severe combined immunodeficiency SCID diseases to be included in the neonatal screening program

Spain, March 26 -- Spain based REVVITY ESPANA SL has secured contract from Organo Administrativo de Recursos Contractuales for Laboratory reagents Supply of reagents for the detection of spinal muscular atrophy SMA and severe combined immunodeficiency SCID diseases to be included in the neonatal screening program. The value of the contract is worth 225900 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....